[Efficacy and tolerance of daily combined treatment of multibacillary leprosy].
D000293:Adolescent; D000328:Adult; D056486:Chemical and Drug Induced Liver Injury; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D011515:Prothionamide / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D013413:Sulfadoxine / Q000008:administration & dosage / Q000627:therapeutic use
D011515:Prothionamide; D013413:Sulfadoxine; D003622:Dapsone; D012293:Rifampin
Efficacité et tolérance d'un traitement combiné quotidien de la lèpre multibacillaire.